Related Experiment Videos

The variance of a better AUC estimator for sparse, destructive sampling in toxicokinetics

J R Nedelman¹, E Gibiansky

¹Department of Drug Metabolism and Pharmacokinetics, Sandoz Research Institute, Sandoz Pharmaceuticals Corporation, East Hanover, NJ 07936, USA.

Journal of Pharmaceutical Sciences

|August 1, 1996

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Population Pharmacokinetics of Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma and Exposure-Response in CLL.

CPT: pharmacometrics & systems pharmacology·2014

Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease.

Gut·2002

Population pharmacodynamics in patients receiving tinzaparin for the prevention and treatment of deep vein thrombosis.

International journal of clinical pharmacology and therapeutics·2001

Mealtime glucose regulation with nateglinide in healthy volunteers: comparison with repaglinide and placebo.

Diabetes care·2001

An extension of Satterthwaite's approximation applied to pharmacokinetics.

Journal of biopharmaceutical statistics·1998

Multiple-dose pharmacokinetics of a long half-life drug: contributions of mathematical modeling.

European journal of drug metabolism and pharmacokinetics·1997

See all related articles